Stay updated on Avutometinib Combo in KRAS G12C NSCLC Clinical Trial
Sign up to get notified when there's something new on the Avutometinib Combo in KRAS G12C NSCLC Clinical Trial page.

Latest updates to the Avutometinib Combo in KRAS G12C NSCLC Clinical Trial page
- Check6 days agoChange DetectedAdded a new 'Locations' section listing recruitment sites across Colorado, District of Columbia, Illinois, Maryland, Massachusetts, Michigan, Minnesota, Missouri, Ohio, Pennsylvania, Texas, Virginia, and Washington; revision updated to v3.3.3.SummaryDifference0.8%

- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check35 days agoChange DetectedPage revision updated from v3.2.0 to v3.3.2. This appears to be a minor metadata update with no changes to study content or displayed details.SummaryDifference0.0%

- Check42 days agoChange DetectedThe government funding notice has been removed from the page. All study details, contacts, and locations remain unchanged.SummaryDifference0.2%

- Check56 days agoChange DetectedNo additions or deletions detected; the Study Details page appears unchanged between screenshots.SummaryDifference0.2%

- Check85 days agoChange DetectedUpdate includes a prominent operating-status notice and a version upgrade from v3.1.0 to v3.2.0. The core effect is informing users about possible delays and the current open status of the NIH Clinical Center.SummaryDifference3%

- Check92 days agoChange DetectedUpdated contact information is added and the page version is upgraded from v3.0.2 to v3.1.0. The most significant change is the page revision, with a large addition of external contact details.SummaryDifference0.1%

Stay in the know with updates to Avutometinib Combo in KRAS G12C NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Avutometinib Combo in KRAS G12C NSCLC Clinical Trial page.